| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
MacKay-Dunn R. Hector is a Director at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 5 buys and 2 sells.
Estimated insider holdings value: $306K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sell | 5,630 | $5.74 | $32,316.20 | -23.2% | +15.2% | +49.2% | |
| May 23, 2023 | AUPH Aurinia Pharmaceuticals Inc. | Director | Sale+OE | 4,818 | $11.26 | $54,250.68 | -16.6% | -15.6% | -51.1% | |
| Mar 9, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 5,000 | $11.00 | $54,985.00 | +83.3% | +7.9% | -16.3% | |
| May 12, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Director | Buy | 4,500 | $11.23 | $50,529.00 | +41.3% | +35.0% | -12.4% |